Roivant Sciences Ltd. (ROIV)

41.85 +0.66 (+1.60%) USD  |  NASDAQ  |  Nov 11, 16:00
41.03 -0.82 (-1.96%) After-Hours: 20:00
More

Roivant Sciences EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for ROIV.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical EPS Diluted (5 Year Growth) Data

View and export this data back to 2024. Start Trial.
Date Value
March 31, 2026 --
March 31, 2025 --
Date Value
March 31, 2024 --

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Bicycle Therapeutics Plc Upgrade
Immunovant, Inc. Upgrade
Adaptimmune Therapeutics Plc --
Kiniksa Pharmaceuticals International Plc Upgrade
Autolus Therapeutics Plc Upgrade